7.65 0.45(6.22%)10/04/2024
Atara Biotherapeutics Inc (ATRA)
Atara Biotherapeutics Inc (ATRA)
Showing latest 10 records. To view more news, Upgrade to PRO plan with only $1
| Headline | Time (ET) | Source |
|---|---|---|
| Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 10/04 16:01 | businesswire.com |
| Atara Biotherapeutics (ATRA) Reports Q2 Loss, Misses Revenue Estimates | 08/12 19:10 | zacks.com |
| Atara Biotherapeutics Announces Second Quarter 2024 Financial Results, Operational Progress and Leadership Update | 08/12 17:00 | businesswire.com |
| All You Need to Know About Atara Biotherapeutics (ATRA) Rating Upgrade to Strong Buy | 07/15 13:01 | zacks.com |
| Atara Biotherapeutics To Participate at the Stifel Virtual Cell Therapy Forum | 07/03 19:57 | businesswire.com |
| Atara Biotherapeutics: An Underestimated Contender In Autoimmune Diseases CAR-T Cell Therapy | 07/03 13:39 | seekingalpha.com |
| Atara Biotherapeutics' Ebvallo™ (tabelecleucel) Wins Prix Galien International Award for Best Product for Orphan/Rare Diseases | 06/21 16:01 | businesswire.com |
| Atara Biotherapeutics Announces 1-for-25 Reverse Stock Split | 06/17 08:00 | businesswire.com |